
| ASSET | DATE | % RETURN |
|---|---|---|
QuantaSing Group Limited American Depositary Shares (QSG) | 1/5/2024 - 1/30/2024 | 152.83% |
Here (HERE) | 1/5/2024 - 1/30/2024 | 152.83% |
Astria Therapeutics (ATXS) | 1/5/2024 - 1/30/2024 | 85.73% |
ADC Therapeutics (ADCT) | 1/5/2024 - 1/30/2024 | 68.95% |
Real Brokerage (REAX) | 1/5/2024 - 1/30/2024 | 64.8% |
Immunome (IMNM) | 1/5/2024 - 1/30/2024 | 60.03% |
Intuitive Machines (LUNR) | 1/5/2024 - 1/30/2024 | 57.41% |
Dianthus Therapeutics (DNTH) | 1/5/2024 - 1/30/2024 | 52.39% |
Neurogene (NGNE) | 1/5/2024 - 1/30/2024 | 51.52% |
Mereo BioPharma Group PLC ADR (MREO) | 1/5/2024 - 1/30/2024 | 50.6% |
Ardelyx (ARDX) | 1/5/2024 - 1/30/2024 | 48.75% |
Solid Biosciences LLC (SLDB) | 1/5/2024 - 1/30/2024 | 46.91% |
Kodiak Sciences (KOD) | 1/5/2024 - 1/30/2024 | 45.67% |
Innodata (INOD) | 1/5/2024 - 1/30/2024 | 42.39% |
Trilogy Metals (TMQ) | 1/5/2024 - 1/30/2024 | 41.22% |
Verastem (VSTM) | 1/5/2024 - 1/30/2024 | 40.58% |
POET Technologies (POET) | 1/5/2024 - 1/30/2024 | 39.78% |
Neuropace (NPCE) | 1/5/2024 - 1/30/2024 | 39.28% |
Cullinan Oncology LLC (CGEM) | 1/5/2024 - 1/30/2024 | 39.21% |
GH Research (GHRS) | 1/5/2024 - 1/30/2024 | 37.86% |
Kura Oncology (KURA) | 1/5/2024 - 1/30/2024 | 34.6% |
PepGen (PEPG) | 1/5/2024 - 1/30/2024 | 34.28% |
Viant Technology (DSP) | 1/5/2024 - 1/30/2024 | 33.33% |
Hyliion (HYLN) | 1/5/2024 - 1/30/2024 | 32.94% |
SEALSQ (LAES) | 1/5/2024 - 1/30/2024 | 32.85% |